Rift Valley fever vaccines
Vaccine, ISSN: 0264-410X, Vol: 27, Issue: SUPPL. 4, Page: D69-D72
2009
- 123Citations
- 143Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations123
- Citation Indexes122
- 122
- CrossRef109
- Patent Family Citations1
- Patent Families1
- Captures143
- Readers143
- 143
Article Description
Rift Valley fever virus (RVFV), which belongs to the genus Phlebovirus, family Bunyaviridae, is a negative-stranded RNA virus carrying a tripartite RNA genome. RVFV is transmitted by mosquitoes and causes large outbreaks among ruminants and humans in Africa and the Arabian Peninsula. Human patients develop an acute febrile illness, followed by a fatal hemorrhagic fever, encephalitis or ocular diseases, whereas ruminants experience abortions during outbreak. Effective vaccination of both humans and ruminants is the best approach to control Rift Valley fever. This article summarizes the development of inactivated RVFV vaccine, live attenuated vaccine, and other new generation vaccines.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0264410X09010548; http://dx.doi.org/10.1016/j.vaccine.2009.07.046; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77955982783&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/19837291; https://linkinghub.elsevier.com/retrieve/pii/S0264410X09010548; https://dx.doi.org/10.1016/j.vaccine.2009.07.046
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know